Factor | HA(n = 61) | non-HA(n = 102) | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | |||
Patient characteristics | ||||||||
Gender | ||||||||
Male | 29 | 62 | 1 | |||||
Female | 32 | 40 | 0.604 | 0.317–1.149 | 0.124 | |||
Age (years)a | 59.6 ± 8.5 | 56.6 ± 9.7 | 1.036 | 1.000–1.074 | 0.051 | |||
Weight loss > 5 kg | ||||||||
Yes | 16 | 31 | 1 | |||||
No | 45 | 71 | 0.621 | 0.284–1.357 | 0.232 | |||
BMI(kg/m2)a | 21.6 ± 3.1 | 21.6 ± 3.3 | 1.000 | 0.884–1.131 | 0.996 | |||
Diabetes mellitus | ||||||||
No | 58 | 97 | 1 | |||||
Yes | 3 | 5 | 1.021 | 0.235–4.433 | 0.978 | |||
Acute pancreatitis | ||||||||
No | 59 | 98 | 1 | |||||
Yes | 2 | 4 | 0.845 | 0.150–4.757 | 0.848 | |||
Chronic pancreatitis | ||||||||
No | 42 | 57 | 1 | |||||
Yes | 19 | 45 | 1.021 | 0.235–4.433 | 0.978 | |||
Preoperative biliary drainage | ||||||||
No | 58 | 94 | 1 | |||||
Yes | 3 | 8 | 0.618 | 0.158–2.427 | 0.491 | |||
Preoperative ALB usage | ||||||||
No | 58 | 97 | 1 | |||||
Yes | 3 | 5 | 0.276 | 0.046–1.638 | 0.157 | |||
Preoperative ALB usage a(g) | 14.7 ± 4.2 | 34.5 ± 9.4 | 0.999 | 0.975–1.023 | 0.910 | |||
WBC(× 109/L)a | 6.6 ± 2.3 | 6.3 ± 2.1 | 1.074 | 0.926–1.247 | 0.346 | |||
NEUT(×109/L)a | 4.6 ± 2.0 | 4.3 ± 1.9 | 1.087 | 0.923–1.280 | 0.319 | |||
LYMP(×109/L)a | 1.2 ± 0.5 | 1.4 ± 0.6 | 0.631 | 0.337–1.182 | 0.151 | |||
CRP (mg/L) a | 16.1 ± 5.4 | 19.7 ± 7.6 | 1.011 | 0.968–1.056 | 0.617 | |||
RBC (× 1012/L)a | 3.8 ± 0.5 | 3.9 ± 0.6 | 0.720 | 0.402–1.290 | 0.270 | |||
Hb(g/L)a | 116.3 ± 17.6 | 119.8 ± 19.4 | 0.990 | 0.973–1.007 | 0.263 | |||
HCT(%)a | 33.6 ± 4.9 | 36.7 ± 4.6 | 0.863 | 0.719–1.035 | 0.112 | |||
PLT (×109/L)a | 206.7 ± 90.4 | 224.6 ± 94.6 | 0.998 | 0.994–1.002 | 0.247 | |||
PT(s)a | 11.5 ± 1.7 | 11.3 ± 1.6 | 1.089 | 0.891–1.330 | 0.406 | |||
APTT(s)a | 28.2 ± 4.7 | 27.4 ± 4.9 | 1.032 | 0.964–1.104 | 0.371 | |||
TT(s)a | 19.8 ± 2.9 | 19.4 ± 2.5 | 1.062 | 0.937–1.203 | 0.346 | |||
INRa | 0.9 ± 0.1 | 0.9 ± 0.2 | 1.763 | 0.180–7.228 | 0.626 | |||
ALT (U/L) a | 112.3 ± 95.2 | 162.3 ± 78.8 | 0.997 | 0.995–1.000 | 0.057 | |||
AST (U/L) a | 96.0 ± 65.1 | 115.6 ± 94.7 | 0.997 | 0.993–1.001 | 0.165 | |||
ALP (U/L) a | 509.3 ± 390.1 | 498.4 ± 374.0 | 1.000 | 0.999–1.001 | 0.861 | |||
TBIL ≥171.1 (μmol/L) | ||||||||
No | 34 | 76 | 1 | |||||
Yes | 27 | 26 | 2.214 | 1.117–4.390 | 0.023 | 0.997 | 0.267–3.720 | 0.997 |
TP (g/L) a | 59.4 ± 2.8 | 61.7 ± 6.0 | 0.905 | 0.755–1.084 | 0.279 | |||
Preoperative ALB ≥35.0 (g/L) | ||||||||
No | 25 | 26 | 1 | |||||
Yes | 36 | 76 | 0.480 | 0.241–0.955 | 0.037 | 0.447 | 0.210–0.952 | 0.037 |
GLB (g/L) a | 25.7 ± 3.5 | 24.9 ± 3.7 | 1.062 | 0.853–1.323 | 0.588 | |||
PA (mg/L) a | 201.8 ± 95.9 | 187.2 ± 71.7 | 1.002 | 0.997–1.007 | 0.366 | |||
AMY (U/L) a | 85.0 ± 59.2 | 145.6 ± 106.3 | 0.996 | 0.988–1.004 | 0.347 | |||
CA19–9 (U/mL)a | 648.5 ± 133.7 | 622.8 ± 147.2 | 1.000 | 1.000–1.000 | 0.941 | |||
Site of Lesion | ||||||||
Distal common bile duct | 18 | 17(16.7) | 1 | 0.262 | ||||
Duodenal papilla | 17(27.9) | 32(31.4) | 0.472 | 0.193–1.155 | 0.100 | |||
Pancreatic head | 21(34.4) | 41(40.2) | 0.561 | 0.234–1.342 | 0.194 | |||
Ampullary | 5(8.2) | 12(11.8) | 0.747 | 0.557–1.003 | 0.052 | |||
Intra-Operative factors | ||||||||
Operation time (h) a | 7.6 ± 1.5 | 7.8 ± 1.7 | 0.923 | 0.754–1.129 | 0.435 | |||
Estimated Blood loss(ml) a | 591.5 ± 451.2 | 497.4 ± 311.1 | 1.001 | 1.000–1.002 | 0.128 | |||
pRBC transfusion (U) a | 1.7 ± 0.6 | 1.5 ± 0.5 | 1.081 | 0.881–1.325 | 0.455 | |||
Plasma transfusion(ml) | 237.5 ± 80.3 | 132.8 ± 50.9 | 1.002 | 1.000–1.004 | 0.009 | 1.002 | 1.000–1.003 | 0.057 |
Total liquid volume(ml) | 5829.2 ± 1431.7 | 6171.3 ± 1544.2 | 1.000 | 1.000–1.000 | 0.275 | |||
Ratio of crystal fluid/colloid fluid | 1.8 ± 0.5 | 2.3 ± 0.6 | 0.219 | 0.046–1.040 | 0.056 | |||
Pancreatic gland texture | ||||||||
Soft | 36 | 58 | 1 | |||||
Hard | 25 | 44 | 0.603 | 0.322–1.129 | 0.114 | |||
Pancreatic duct diameter > 0.3 cm | ||||||||
No | 27 | 25 | 1 | 1 | ||||
Yes | 34 | 77 | 0.425 | 0.215–0.839 | 0.014 | 0.819 | 0.369–1.815 | 0.622 |
PJ-R Type | ||||||||
IPJ (external stenting) | 49 | 81 | 1 | 0.219 | ||||
DMPJ (external stenting) | 0 | 2 | – | – | – | |||
DMPJ (internal stenting) | 4 | 14 | 1.189 | 0.449–3.152 | 0.728 | |||
IPJ (no stenting) | 5 | 4 | 5.833 | 0.953–7.717 | 0.056 | |||
IPJ (internal stenting) | 3 | 1 | 1.460 | 0.914–2.330 | 0.113 | |||
Combined portal vein resection | ||||||||
No | 60 | 100 | 1 | |||||
Yes | 1 | 2 | 1.180 | 0.105–3.296 | 0.893 | |||
Resectional margin status | ||||||||
R0b | 53 | 91 | 1 | 0.697 | ||||
R1 | 5 | 5 | 1.692 | 0.468–6.124 | 0.423 | |||
R2 | 3 | 6 | 1.046 | 0.559–1.956 | 0.889 | |||
Pathological characteristics and postoperative complications | ||||||||
Pathology | ||||||||
Adenocarcinoma | 59(96.7) | 85(83.3) | 1 | 0.949 | ||||
Mucinous adenocarcinoma | 0(0) | 5(4.9) | – | – | – | |||
Inflammation mass | 2 | 10 | 0.754 | 0.565–1.005 | 0.054 | |||
Sarcoma | 0 | 1 | – | – | – | |||
Retention cyst | 0 | 1 | – | – | – | |||
Tumor Differentiation | ||||||||
Inflammation | 2 | 11 | 1 | 0.570 | ||||
High | 26 | 45 | 0.900 | 0.356–2.274 | 0.824 | |||
Moderate | 23 | 27 | 1.033 | 0.592–3.974 | 0.379 | |||
Poor | 10 | 19 | 1.167 | 0.758–1.797 | 0.484 | |||
Clavien-Dindo grade | ||||||||
0 | 28 | 61 | 1 | 0.262 | 1 | 0.173 | ||
I | 11 | 25 | 0.472 | 0.193–1.155 | 0.100 | 0.620 | 0.105–3.656 | 0.597 |
II | 12 | 6 | 0.561 | 0.234–1.342 | 0.194 | 1.127 | 0.179—7.085 | 0.899 |
IIIa | 2 | 5 | 3.765 | 0.897–9.296 | 0.067 | 1.582 | 0.316–7.927 | 0.577 |
IIIb | 2 | 4 | 3.351 | 1.641–6.845 | 0.001 | 4.317 | 1.479–12.602 | 0.007 |
IVa | 2 | 0 | – | – | – | – | – | – |
IVb | 0 | 0 | – | – | – | – | – | – |
V | 4 | 1 | 1.654 | 1.186–2.306 | 0.003 | 1.605 | 1.097–2.349 | 0.015 |